FXN and Friedreich ataxia: The present meta-analysis explored the effect of different types of interventions targeting mitochondrial function, frataxin, or patients’ symptoms on clinical, cardiac, biochemical, PROMs, imaging, or neurophysiologic biomarkers in 1409 patients with Friedreich ataxia.